Bioventix (BVXP)

Company name:	Bioventix Plc
EPIC:	BVXP	Trading Currency:	GBX
Market Sector:	AMQ1	ISIN:	GB00B4QVDF07
Market Segment:	ASQ1	Share Type:	DE
WWW Address:	http://www.bioventix.com/investors.htm	Description:	ORD 5P
Industry Sector:	PHARMACEUTICALS & BIOTECHNOLOGY

Price	Price Change [%]	Bid	Offer	Open	High	Low	Volume
3,945.00	25.0 [0.64]	3,920.00	3,970.00	3,925.00	3,945.00	3,925.00	2,195
Market Cap. [m]	Shares In Issue [m]	Beta	EPS	DPS	PE Ratio	Yield	52-Wks-Range
205.51	5.21	-0.61	139.41	78.00	28.30	1.98	4,290.00 - 2,915.00

Bioventix Key Figures

(at previous day's close)
Market Cap.	205.51	m
Shares In Issue	5.21	m
Prev. Close	3,920.00
PE Ratio	28.30
Dividend Yield	1.98	%
EPS - basic	139.41	p
Dividend PS	78.00	p
Dividend Cover	1.79
Cash Flow PS	147.48	p
Return On Equity (ROE)	57.53	%
Operating Margin	79.75	%
PEG Factor	1.27
EPS Growth Rate	22.25	%
Dividends PS Growth Rate	6.85	%
Net Debt	-7.30	m
Gross Gearing	5.86	%
Quick Assets	11.73	m
Net Working Capital	11.24	m
Intangibles / Fixed Assets	-	%
Turnover PS	197.98	p
Pre-Tax Profit PS	157.89	p
Retained Profit PS	13.43	p
Cash PS	155.04	p
Net Cash PS	141.05	p
Net Tangible Asset Value PS *	240.36	p
Net Asset Value PS	240.36	p
Spread	50.00 (1.26%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Bioventix Balance Sheet

Share Price Performance

Sample Period ^†	High	Low
1 week	4,085.00	3,895.00
4 weeks	4,290.00	3,895.00
12 weeks	4,290.00	3,300.00
1 year	4,290.00	2,915.00

Share Price Chart (5 years)

Bioventix Historic Returns

Period ^†	Open	Change	%	Open Avg.	Avg. Daily Vol [m]	Total Vol [m]	VWAP
1 week	4,085.00	-140.00	-3.43	3,895.00	0.00		4,021.25
4 weeks	4,050.00	-105.00	-2.59	3,895.00	0.00		4,098.55
12 weeks	3,300.00	645.00	19.55	3,300.00	0.00		3,841.79
26 weeks	3,425.00	520.00	15.18	3,115.00	0.01		3,522.49
1 year	3,035.00	910.00	29.98	2,915.00	0.01		3,442.95
3 years	3,985.00	-40.00	-1.00	2,260.00	0.01		3,704.13
5 years	2,500.00	1,445.00	57.80	2,000.00	0.01		3,486.06
† periods calculated are whole weeks rather than calendar months

Bioventix Key Management Ratios

Bioventix Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio	1.57
PE Ratio	28.30
Tobin's Q Ratio	16.50
Tobin's Q Ratio (excl. intangibles)	16.50
Dividend Yield	1.98	%
Market-to-Book Ratio	16.41
Price-to-Pre-Tax Profit PS	24.99
Price-to-Retained Profit PS	293.81
Price-to-Cash Flow PS	26.75
Price-to-Sales PS	19.93
Price-to-Net Tangible Asset Value PS	16.41
Price-to-Cash PS	25.45
Net Working Capital PS	215.82
Price Pct to Working Capital PS	18.28	%
Earnings Yield	3.53	%
Average PE	24.59
Years in average	5
PE to PE average	115.06	%

Bioventix Financial Ratios

(Leverage Ratios)
Debt Ratio	0.40	%
Debt-to-Equity Ratio	0.00
Debt-to-Equity Ratio (excl. Intgbl)	0.00
Debt-to-Equity Market Value	0.00
Net Gearing	-54.87	%
Net Gearing (excl. Intangibles)	-54.87	%
Gross Gearing	5.86	%
Gross Gearing (excl. Intangibles)	5.86	%
Gearing Under 1 Year	5.48	%
Gearing Under 1 Year (excl. Intgbl)	5.48	%
Assets/Equity	1.06
Cash/Equity	64.50
(Liquidity Ratios)
Net Working Capital to Total Assets	84.53	%
Current Ratio	16.43
Quick Ratio (Acid Test)	16.09
Liquidity Ratio	11.08
Cash & Equiv/Current Assets	67.47	%
(Solvency Ratios)
Enterprise Value	197.48	m
CFO/Sales	0.74
CFO/Attributable Profit	1.07
CFO/Assets	0.58
CFO/Debt	9.86
Total Debt/Equity Market Value	0.00
Total Debt/Sales	0.08
Total Debt/Pre-Tax Profit	0.09
Total Debt	0.78	m
Total Debt/Net Current Assets	0.07	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	8.15	%
5 yr Compound Earnings Growth	15.04	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	-

Beta (60-Mnth)	Beta (36-Mnth)
-0.6140	-0.4386

Bioventix Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)	65.43	%
Return On Assets (ROA)	57.82	%
Net Profit Margin	69.84	%
Assets Turnover	0.83
Return On Equity (ROE)	57.53	%
Return On Investment (ROI)	61.49	%
Dividend Payout Ratio	55.95	%
Plowback Ratio	44.05	%
Growth from Plowback Ratio	27.18	%
Net Income Of Revenues	6.78	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	0.88
Fixed Assets Turnover	9.24
Current Assets Turnover	0.91
Net Working Capital Turnover
Inventory Turnover	42.55
(Other Operating Ratios)
Total Assets-to-Sales	1.21
Debtors-to-Sales	36.76	%
Debt Collection Period	134.19	Days

Bioventix Dividends

Announcement Date	Type	Curr.	Dividend Amount	Period Start	Period End	Ex Date	Record Date	Payment Date	Total Dividend Amount
29 Mar 2022	Interim	GBX	52.00	01/07/2021	31/12/2021	07/04/2022	08/04/2022	22/04/2022	-
18 Oct 2021	Special	GBX	38.00	30/06/2020	30/06/2021	28/10/2021	29/10/2021	12/11/2021	-
18 Oct 2021	Interim	GBX	62.00	30/06/2020	30/06/2021	28/10/2021	29/10/2021	12/11/2021	105.00
29 Mar 2021	Interim	GBX	43.00	01/07/2020	31/12/2020	08/04/2021	09/04/2021	23/04/2021	-
19 Oct 2020	Special	GBX	53.00	30/06/2019	30/06/2020	29/10/2020	30/10/2020	13/11/2020	-
19 Oct 2020	Interim	GBX	52.00	30/06/2019	30/06/2020	29/10/2020	30/10/2020	13/11/2020	78.00
30 Mar 2020	Interim	GBX	36.00	01/07/2019	31/12/2019	09/04/2020	14/04/2020	28/04/2020	-
21 Oct 2019	Interim	GBX	43.00	30/06/2018	30/06/2019	31/10/2019	01/11/2019	15/11/2019	73.00
21 Oct 2019	Special	GBX	47.00	30/06/2018	30/06/2019	31/10/2019	01/11/2019	15/11/2019	-
29 Mar 2019	Interim	GBX	30.00	01/07/2018	31/12/2018	11/04/2019	12/04/2019	26/04/2019	-
08 Oct 2018	Interim	GBX	36.00	30/06/2017	30/06/2018	25/10/2018	26/10/2018	09/11/2018	61.00
08 Oct 2018	Special	GBX	55.00	30/06/2017	30/06/2018	25/10/2018	26/10/2018	09/11/2018	-
26 Mar 2018	Interim	GBX	25.00	01/07/2017	31/12/2017	05/04/2018	06/04/2018	20/04/2018	-
16 Oct 2017	Interim	GBX	31.00	30/06/2016	30/06/2017	26/10/2017	27/10/2017	10/11/2017	51.00
16 Oct 2017	Special	GBX	20.00	30/06/2016	30/06/2017	26/10/2017	27/10/2017	10/11/2017	-
27 Mar 2017	Interim	GBX	20.00	01/07/2016	31/12/2016	06/04/2017	07/04/2017	21/04/2017	-
17 Oct 2016	Interim	GBX	26.00	30/06/2015	30/06/2016	27/10/2016	28/10/2016	11/11/2016	42.50
17 Oct 2016	Special	GBX	20.00	30/06/2015	30/06/2016	27/10/2016	28/10/2016	11/11/2016	-
21 Mar 2016	Interim	GBX	16.50	01/07/2015	31/12/2015	07/04/2016	08/04/2016	22/04/2016	-
05 Oct 2015	Final	GBX	21.60	30/06/2014	30/06/2015	15/10/2015	16/10/2015	30/10/2015	32.60
30 Mar 2015	Interim	GBX	11.00	01/07/2014	31/12/2014	09/04/2015	10/04/2015	24/04/2015	-
07 Oct 2014	Final	GBX	14.40	30/06/2013	30/06/2014	16/10/2014	17/10/2014	31/10/2014	24.00
24 Apr 2014	Interim	GBX	9.60	01/07/2013	31/12/2013	08/05/2014	09/05/2014	27/05/2014	-

Bioventix Fundamentals

	30 Jun 2017 (GBP)		30 Jun 2018 (GBP)		30 Jun 2019 (GBP)		30 Jun 2020 (GBP)
turnover	7.25	100.00%	7.98	100.00%	9.29	100.00%	10.31	100.00%	m
pre tax profit	5.77	79.66%	6.87	86.06%	6.97	74.98%	8.23	79.75%	m
attributable profit	4.92	67.93%	5.66	70.98%	5.86	63.10%	7.20	69.84%	m
retained profit	1.55	21.38%	5.66	70.98%	-0.36	-3.87%	0.70	6.78%	m
eps - basic (p)	96.36		110.21		114.04		139.41
eps - diluted (p)	94.70		108.31		112.12		137.93
dividends per share	51.00		61.00		73.00		78.00

Bioventix Balance Sheet

	30 Jun 2017 (GBP)		30 Jun 2018 (GBP)		30 Jun 2019 (GBP)		30 Jun 2020 (GBP)


	30 Jun 2017 (GBP)		30 Jun 2018 (GBP)		30 Jun 2019 (GBP)		30 Jun 2020 (GBP)
ASSETS
fixed assets	0.45	4.33%	0.50	4.19%	0.51	4.43%	0.72	5.40%	m
intangibles	-	-%	-	-%	-	-%	-	-%	m
fixed investments	0.20	1.88%	0.29	2.45%	0.39	3.34%	0.61	4.59%	m
current assets - other	-	-%	-	-%	-	-%	-	-%	m
stocks	0.23	2.18%	0.28	2.38%	0.24	2.06%	0.25	1.85%	m
debtors	3.34	32.20%	3.82	32.14%	3.93	33.87%	3.65	27.44%	m
cash & securities	6.17	59.41%	6.99	58.83%	6.54	56.29%	8.08	60.73%	m

TOTAL	10.38	100%	11.88	100%	11.61	100%	13.30	100%	m

LIABILITIES
creditors - short	0.22	2.12%	0.84	7.06%	0.76	6.51%	0.73	5.48%	m
creditors - long	-	-%	-	-%	-	-%	-	-%	m
creditors - other	0.02	0.16%	0.03	0.22%	0.03	0.27%	0.05	0.38%	m
subordinated loans	-	-%	-	-%	-	-%	-	-%	m
insurance funds	-	-%	-	-%	-	-%	-	-%	m

TOTAL	0.24	2.27%	0.86	7.28%	0.79	6.78%	0.78	5.86%	m

EQUITY
ord cap, reserves	10.14	97.73%	11.01	92.72%	10.83	93.22%	12.52	94.14%	m
prefs, minorities	-	-%	-	-%	-	-%	-	-%	m

TOTAL	10.14	97.73%	11.01	92.72%	10.83	93.22%	12.52	94.14%	m

OTHER
NAV Basic	-		-		-		-
NAV Diluted	-		-		-		-

Bioventix Cash Flow Statement

	30 Jun 2017 (GBP)	30 Jun 2018 (GBP)	30 Jun 2019 (GBP)	30 Jun 2020 (GBP)
Operating CF	3.89	5.92	5.88	7.68	m
Pre-Financing CF	3.84	5.75	5.73	7.16	m
Retained CF	0.79	0.82	-0.45	1.54	m

Bioventix Brokers

Broker infomation is not available for this class of stock.